Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

MNKD MannKind Corporation

4,32

0,01 (0,23%)

11 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

MannKind (NASDAQ:MNKD)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more MannKind Charts.

MannKind (NASDAQ:MNKD)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more MannKind Charts.

News MannKind Corporation

MannKind Corporation Reports 2024 First Quarter Financial Results: Provides Clinical Development Update
Mittwoch 8 Mai 2024 (4 Tage vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 8 Mai 2024 (4 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 8 Mai 2024 (4 Tage vor) • Edgar (US Regulatory)

MannKind Receives U.S. FDA Fast Track Designation for Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease
Montag 6 Mai 2024 (7 Tage vor) • GlobeNewswire Inc.

MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024
Mittwoch 1 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

MannKind to Proceed With Phase 1 Nintedanib Dpi (Mnkd-201) Study for Pulmonary Fibrotic Diseases
Dienstag 30 April 2024 (2 Wochen vor) • GlobeNewswire Inc.

MannKind Announces IND Clearance From U.S. FDA to Start Phase 3 Study of Clofazimine Inhalation Suspension for Nontuberculous Mycobacterial (NTM) Lung Disease
Montag 29 April 2024 (2 Wochen vor) • GlobeNewswire Inc.

MannKind Repays Certain Debt Obligations
Mittwoch 3 April 2024 (1 Monat vor) • GlobeNewswire Inc.

MannKind Announces CFO Transition
Dienstag 26 März 2024 (2 Monate vor) • GlobeNewswire Inc.

INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps
Montag 11 März 2024 (2 Monate vor) • GlobeNewswire Inc.

MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8
Dienstag 5 März 2024 (2 Monate vor) • GlobeNewswire Inc.

MannKind Corporation Announces Participation at Upcoming Conferences
Montag 4 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere MannKind Corporation News-Artikel

Invesco QQQ Trust Series 1

Deutsche Telekom (QX)

Health Care Select Sector

Euro vs US Dollar

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen